Skip to main content

Post-IPO Equity Companies in Waltham

Explore 12 post-ipo equity startups based in Waltham, United States. Access verified founder contact information and fundraising data.

Total Companies
12
Total Funding
$2.2B
Avg Funding
$187.3M
Industries
4

Export 12 Post-IPO Equity Companies in Waltham

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$12.0M
raised

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$66.0M
raised

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$150.0M
raised

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$276.0M
raised

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$700.4M
raised

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 12 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$100.0M
raised

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$719.0M
raised

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$40.0M
raised

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Analytics
$23.5M
raised

Bigtincan is a sales enablement automation company that helps brands facilitate the future buying experience.

Dec 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 12 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$125.0M
raised

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$5.9M
raised

Vicarious Surgical is a robotics company that develops robotic systems that allow surgeons to perform minimally invasive surgery.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Equity Startups in Waltham?

Get verified founder emails, funding details, and company data for 12 post-ipo equity companies in Waltham.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked